- Home
- ASH vs LGND Comparison
ASH vs LGND Comparison
Compare ASH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASH
- LGND
- Stock Information
- Founded
- ASH 1924
- LGND 1987
- Country
- ASH United States
- LGND United States
- Employees
- ASH N/A
- LGND N/A
- Industry
- ASH Specialty Chemicals
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ASH Consumer Discretionary
- LGND Health Care
- Exchange
- ASH Nasdaq
- LGND Nasdaq
- Market Cap
- ASH 2.4B
- LGND 2.0B
- IPO Year
- ASH N/A
- LGND 1992
- Fundamental
- Price
- ASH $50.48
- LGND $104.97
- Analyst Decision
- ASH Buy
- LGND Strong Buy
- Analyst Count
- ASH 6
- LGND 7
- Target Price
- ASH $83.20
- LGND $144.67
- AVG Volume (30 Days)
- ASH 846.5K
- LGND 127.9K
- Earning Date
- ASH 04-30-2025
- LGND 05-06-2025
- Dividend Yield
- ASH 3.21%
- LGND N/A
- EPS Growth
- ASH N/A
- LGND N/A
- EPS
- ASH N/A
- LGND N/A
- Revenue
- ASH $2,045,000,000.00
- LGND $167,133,000.00
- Revenue This Year
- ASH N/A
- LGND $16.47
- Revenue Next Year
- ASH $2.61
- LGND $19.44
- P/E Ratio
- ASH N/A
- LGND N/A
- Revenue Growth
- ASH N/A
- LGND 27.28
- 52 Week Low
- ASH $45.21
- LGND $67.72
- 52 Week High
- ASH $102.50
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ASH 40.39
- LGND 47.85
- Support Level
- ASH $49.00
- LGND $100.30
- Resistance Level
- ASH $51.37
- LGND $107.62
- Average True Range (ATR)
- ASH 2.97
- LGND 6.00
- MACD
- ASH -0.03
- LGND 0.59
- Stochastic Oscillator
- ASH 36.47
- LGND 74.98
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.